Independence Bank of Kentucky’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-517
Closed -$24.9K 619
2026
Q1
$24.9K Sell
517
-76
-13% -$3.54K ﹤0.01% 472
2025
Q4
$28.7K Buy
593
+76
+15% +$3.77K ﹤0.01% 464
2025
Q3
$24.4K Hold
517
﹤0.01% 472
2025
Q2
$25K Hold
517
﹤0.01% 468
2025
Q1
$28.7K Hold
517
﹤0.01% 444
2024
Q4
$24.9K Hold
517
﹤0.01% 455
2024
Q3
$29.8K Buy
517
+450
+672% +$24.3K 0.01% 414
2024
Q2
$3.25K Sell
67
-67
-50% -$3.23K ﹤0.01% 503
2024
Q1
$6.51K Hold
134
﹤0.01% 461
2023
Q4
$6.66K Buy
+134
New +$6.55K ﹤0.01% 452
2023
Q3
Sell
-200
Closed -$10.8K 513
2023
Q2
$10.8K Hold
200
﹤0.01% 378
2023
Q1
$10.9K Hold
200
﹤0.01% 350
2022
Q4
$10K Hold
200
﹤0.01% 356
2022
Q3
$8K Hold
200
﹤0.01% 355
2022
Q2
$10K Buy
+200
New +$10.6K ﹤0.01% 347

Other funds holding SNY

Independence Bank of Kentucky's SNY Position: Q2 2026 in Review

Independence Bank of Kentucky sold out of Sanofi (SNY) in Q2 2026, closing a stake of 517 shares — an estimated $24.9K sold.

Independence Bank of Kentucky first reported a position in SNY in Q2 2022 and held it in 15 quarters. The position peaked at $29.8K in Q3 2024. 524 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Independence Bank of Kentucky reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Independence Bank of Kentucky sold 517 Sanofi shares in Q2 2026, an estimated $24.9K.
  • Independence Bank of Kentucky first reported a position in Sanofi in Q2 2022 and held it in 15 quarters.
  • Independence Bank of Kentucky's Sanofi position peaked at $29.8K in Q3 2024.
  • 524 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.